Napoleone Ferrara - Top Italian Scientist in Biomedical Sciences
Napoleone Ferrara (born 26 July 1956, Catania), is an Italian-American molecular biologist who joined University of California, San Diego Moores Cancer Center in 2013 after a career in Northern California at the biotechnology giant Genentech, where he pioneered the development of new treatments for angiogenic diseases such as cancer, age-related macular degeneration (AMD), and diabetic retinopathy. At Genentech, he discovered VEGF—and made the first anti-VEGF antibody—which suppresses growth of a variety of tumors. These findings helped lead to development of the first clinically available angiogenesis inhibitor, bevacizumab (Avastin), which prevents the growth of new blood vessels into a solid tumor and which has become part of standard treatment for a variety of cancers.[citation needed] Ferrara's work led also to the development of ranibizumab (Lucentis), a drug that is highly effective at preventing vision loss in intraocular neovascular disorders.
 


H-Index: 172
Citations: 166138
Nation: USA
Area: cancer - medicine
Macroarea: Biomedical Sciences
Google Scholar My Citations: https://scholar.google.co.uk/citations?user=WPJnV70AAAAJ
Last Update: 2/9/2020 10:12:15 AM